Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grit Zahn

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|July 10, 2007
Design and synthesis of a new class of selective integrin alpha5beta1 antagonistsRoland Stragies, Frank Osterkamp, Gunther Zischinsky, et al.
Molecular and Cellular Neurosciences|September 23, 2008
An alpha5beta1 integrin inhibitor attenuates glioma growthKatrin Färber, Michael Synowitz, Grit Zahn, et al.
Molecular Pharmacology|March 11, 2006
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonistNaoyasu Umeda, Shu Kachi, Hideo Akiyama, et al.
Experimental Eye Research|July 31, 2007
The role of integrin alpha5beta1 in the regulation of corneal neovascularizationPhilipp S Muether, Susanne Dell, Norbert Kociok, et al.
Journal of Clinical Medicine|August 10, 2024
Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal TransplantationTina Dietrich-Ntoukas, Felix Bock, Jasmine Onderka, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2009
Breaking the dogma of the metal-coordinating carboxylate group in integrin ligands: introducing hydroxamic acids to the MIDAS to tune potency and selectivityDominik Heckmann, Burkhardt Laufer, Luciana Marinelli, et al.
The American Journal of Pathology|June 27, 2007
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockadeTina Dietrich, Jasmine Onderka, Felix Bock, et al.
BMC Medicine|December 19, 2023
The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug developmentDipender Gill, Loukas Zagkos, Rubinder Gill, et al.
Cancer Metastasis Reviews|December 21, 2021
Extracellular citrate and metabolic adaptations of cancer cellsE Kenneth Parkinson, Jerzy Adamski, Grit Zahn, et al.
Journal of Leukocyte Biology|January 26, 2010
Inflammation-dependent alpha 5 beta 1 (very late antigen-5) expression on leukocytes reveals a functional role for this integrin in acute peritonitisAndré L F Sampaio, Grit Zahn, Giovanna Leoni, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|July 10, 2007
Design and synthesis of a new class of selective integrin alpha5beta1 antagonistsRoland Stragies, Frank Osterkamp, Gunther Zischinsky, et al.
Molecular and Cellular Neurosciences|September 23, 2008
An alpha5beta1 integrin inhibitor attenuates glioma growthKatrin Färber, Michael Synowitz, Grit Zahn, et al.
Molecular Pharmacology|March 11, 2006
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonistNaoyasu Umeda, Shu Kachi, Hideo Akiyama, et al.
Experimental Eye Research|July 31, 2007
The role of integrin alpha5beta1 in the regulation of corneal neovascularizationPhilipp S Muether, Susanne Dell, Norbert Kociok, et al.
Journal of Clinical Medicine|August 10, 2024
Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal TransplantationTina Dietrich-Ntoukas, Felix Bock, Jasmine Onderka, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2009
Breaking the dogma of the metal-coordinating carboxylate group in integrin ligands: introducing hydroxamic acids to the MIDAS to tune potency and selectivityDominik Heckmann, Burkhardt Laufer, Luciana Marinelli, et al.
The American Journal of Pathology|June 27, 2007
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockadeTina Dietrich, Jasmine Onderka, Felix Bock, et al.
BMC Medicine|December 19, 2023
The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug developmentDipender Gill, Loukas Zagkos, Rubinder Gill, et al.
Cancer Metastasis Reviews|December 21, 2021
Extracellular citrate and metabolic adaptations of cancer cellsE Kenneth Parkinson, Jerzy Adamski, Grit Zahn, et al.
Journal of Leukocyte Biology|January 26, 2010
Inflammation-dependent alpha 5 beta 1 (very late antigen-5) expression on leukocytes reveals a functional role for this integrin in acute peritonitisAndré L F Sampaio, Grit Zahn, Giovanna Leoni, et al.
Pageof 4